Short term neoadjuvant androgen deprivation therapy does not affect prostate specific membrane antigen expression in prostate tissues Academic Article Article uri icon

Overview

MeSH Major

  • Nomograms
  • Prostate-Specific Antigen
  • Prostatic Neoplasms

abstract

  • Short term neoadjuvant ADT does not affect PSMA expression in benign prostate secretory-acinar epithelium, high grade PIN, or prostate carcinoma. Prostate carcinoma and high grade PIN express significantly higher levels of PSMA than benign prostate secretory-acinar epithelium. Compared with 7E11, the PM2J004.5 anti-PSMA mAb is a more sensitive immunohistochemical marker of prostate carcinoma in formalin fixed, paraffin embedded tissue.

publication date

  • January 15, 2000

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1002/(SICI)1097-0142(20000115)88:2<407::AID-CNCR23>3.0.CO;2-0

PubMed ID

  • 10640975

Additional Document Info

start page

  • 407

end page

  • 15

volume

  • 88

number

  • 2